Successfully treated hyperthyroid cats face long-term management challenges including emerging kidney disease and monitoring requirements that significantly affect quality of life.
Feline hyperthyroidism management is a paradigm case of medicine improving welfare: affected cats experience weight loss, muscle wasting, vomiting, hypertension, and cardiac changes that cause significant discomfort. Effective treatment reverses most of these signs dramatically, restoring body condition and comfort. However, the post-treatment period requires careful monitoring because hyperthyroidism elevates glomerular filtration rate — masking kidney disease — and successful treatment may reveal significant underlying CKD. The welfare implication is that over-aggressive treatment can precipitate acute kidney injury in cats with marginal renal function. Targeting a T4 level in the lower-normal range rather than the subnormal range helps balance thyroid and renal welfare. Regular monitoring enables dose adjustment that maintains both thyroid control and kidney health.